case_images: PMC8511520_01
case_images: Facial eczema prior to (A) and after (B) starting treatment with dupilumab. (C,D) Show lesions on the right leg and right ear, respectively, prior to dupilumab treatment. Although corresponding images for (C,D) after treatment were not captured, the lesions seen prior to treatment resolved after dupilumab treatment.
case_images: fped-09-646997-g0001.jpg
case_images: PMC8511520_01_fped-09-646997-g0001.jpg
case_images: F1
case_images: Furthermore, the patient was able to discontinue topical and systemic steroids (Figure 1).
case_images: Timeline illustrating the development of our patient's clinical phenotype and improvement following dupilumab. Interventions are indicated in red. HSV, herpes simplex virus; IgE, immunoglobulin E; IVIG, intravenous immunoglobulin; MRSA, methicillin resistant Staphylococcus aureus; TMP/SMX, trimethoprim/sulfamethoxazole.
case_images: fped-09-646997-g0002.jpg
case_images: PMC8511520_01_fped-09-646997-g0002.jpg
case_images: F2
case_images: A timeline illustrating the development of our patient's clinical phenotype and treatment is summarized in Figure 2.